Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 4, 2025 4:00 P.M.
Form:
S-3
CIK:
0001725160
Company Name:
Zentalis Pharmaceuticals, Inc.
File Number:
333-286122